Optimi Health Corp. SEC filings OPTH
Optimi Health Corp. has 47 filings in SEC EDGAR's recent list, going back to Jun 26, 2024. The most recent current report (Form 6-K) was filed on Oct 26, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 20, 2026 | Oct 20, 2026 |
| 6-K | Current report (foreign issuer) | Oct 7, 2026 | Oct 7, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 5, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 29, 2026 | Sep 29, 2026 |
| 6-K | Current report (foreign issuer) | Sep 23, 2026 | Sep 23, 2026 |
| 6-K | Current report (foreign issuer) | Sep 22, 2026 | Sep 22, 2026 |
| 6-K | Current report (foreign issuer) | Sep 16, 2026 | Sep 16, 2026 |
| 6-K | Current report (foreign issuer) | Sep 10, 2026 | Sep 10, 2026 |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 424B3 | Prospectus | Aug 27, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 27, 2026 | Aug 26, 2026 |
| EFFECT | Filing | Aug 25, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Aug 17, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 14, 2026 | Aug 14, 2026 |
| 6-K | Current report (foreign issuer) | Aug 14, 2026 | Jun 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 7, 2026 | Aug 7, 2026 |
| 6-K | Current report (foreign issuer) | Jul 28, 2026 | Jul 28, 2026 |
| 6-K | Current report (foreign issuer) | Jul 20, 2026 | Jul 20, 2026 |
| S-8 | Employee stock plan registration | Jul 7, 2026 | — |
| 6-K | Current report (foreign issuer) | Jun 29, 2026 | Jun 29, 2026 |
| 6-K | Current report (foreign issuer) | Jun 16, 2026 | Jun 16, 2026 |
| 6-K | Current report (foreign issuer) | Jun 10, 2026 | Jun 10, 2026 |
| 6-K | Current report (foreign issuer) | Jun 8, 2026 | Jun 8, 2026 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 2, 2026 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 1, 2026 |
| 6-K | Current report (foreign issuer) | May 29, 2026 | May 29, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 27, 2026 | — |
| 6-K | Current report (foreign issuer) | May 26, 2026 | May 26, 2026 |
| 424B4 | Prospectus | May 20, 2026 | — |
| EFFECT | Filing | May 19, 2026 | — |
| CERT | Filing | May 19, 2026 | — |
| 8-A12B | Filing | May 19, 2026 | — |
| F-1/A | Filing | May 19, 2026 | — |
| F-1/A | Filing | Apr 23, 2026 | — |
| F-1/A | Filing | Apr 21, 2026 | — |
| F-1/A | Filing | Apr 21, 2026 | — |
| F-1/A | Filing | Apr 16, 2026 | — |
| F-1/A | Filing | Mar 24, 2026 | — |
| F-1/A | Filing | Mar 13, 2026 | — |
| F-1/A | Filing | Feb 17, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Sep 5, 2025 | — |
| DRS/A | Filing | Aug 8, 2025 | — |
| DRS | Filing | Jun 16, 2025 | — |
| D | Filing | Aug 26, 2024 | — |
| D | Filing | Jun 26, 2024 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OPTH (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC CIK
- 2027329
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.